Stoyanova Lab News
Dr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant
Dr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant
“An automated disposable tool for liquid biopsy-based detection of exosomal biomarkers for early cancer detection”
Discovery of ferroptosis inducers as a new therapeutic strategy for advanced prostate cancer
New study from our lab demonstrates that ferroptosis inducers represent a new therapeutic approach for advanced prostate cancer.
Identification of a new serum biomarker for clinically significant prostate cancer
Exciting new results from our lab collaborative work reveal PTN as a new serum biomarker of pro-metastatic prostate cancer. Congratulations Shiqin and all collaborators!
Identification of a new important regulator of prostate cancer growth and metastasis
New study from our lab demonstrates plectin is an important regulator of prostate cancer growth and metastatic colonization. Congratulations Mark, Meghan and team.
Tanya Stoyanova receives 2020 Society of Basic Urologic Research Young Investigator Award from the Society of Basic Urologic Research
Congratulations Tanya!
En-chi Hsu receives Travel Award from the Society of Basic Urologic Research
Congratulations En-chi!
Merve Aslan receives Travel Award from the Society of Basic Urologic Research
Congratulations Merve!
Exciting news: Dr. Manoj Kumar joins Stoyanova lab!
Welcome to the team Manoj!
New review article on prostate cancer therapies published
Stoyanova Lab publishes a review article discussing second-generation anti-androgen therapies for prostate cancer. Congratulations Meghan!
Stoyanova Lab Receives NCI R01 Grant
Stoyanova lab is awarded NIH/NCI R01 funding for the proposal entitled:
“Elucidating the Role of UCHL1 in Aggressive Prostate Cancer”
The goal of the project is to identify new molecular mechanisms underlying the development of highly aggressive neuroendocrine prostate cancer and develop new therapies for the matasatic disease.
Congratulations!